Skip to content

Evaluation of the Efficacy of Scalp Electroacupuncture for Post-Stroke Disorders of Consciousness with Exploratory fMRI and EEG Assessments

Evaluation of the Efficacy of Scalp Electroacupuncture for Post-Stroke Disorders of Consciousness with Exploratory fMRI and EEG Assessments

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126438
Enrollment
Unknown
Registered
2026-06-09
Start date
2026-06-09
Completion date
Unknown
Last updated
2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke disorders of consciousness

Interventions

Experimental group:Conventional treatment plus neuroimaging-based electro-scalp acupuncture (NESA)
Control group:Conventional treatment alone

Sponsors

Xuanwu Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 - 80 years old; 2. Meets the diagnostic criteria for ischemic stroke as stipulated in the "Chinese Guidelines for the Management of Severe Stroke 2024", confirmed by cranial CT or MRI examination, and the onset time is more than 7 days; 3. Glasgow Coma Scale score < 12; 4. The modified Rankin score before this onset was < 2; 5. Stroke is the sole cause of consciousness disorder, and other diseases or factors that may cause consciousness disorder are excluded; 6. The patient's family signed the informed consent form in accordance with ethical requirements.

Exclusion criteria

Exclusion criteria: 1. Patients with significant skull defect; 2. Those with a history of epilepsy, or whose clinical manifestations suggest epileptic seizures or whose electroencephalogram shows epileptic discharges; 3. Patients whose expected survival period due to various serious diseases is less than 3 months; 4. Pregnant women, lactating women, or those with positive pregnancy test upon admission; 5. Patients currently participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Coma Recovery Scale–Revised (CRS-R) total score;

Secondary

MeasureTime frame
Glasgow Coma Scale (GCS) score;Glasgow Outcome Scale–Extended (GOSE) score;Full Outline of Unresponsiveness (FOUR) score;modified Rankin Scale (mRS) score;

Countries

China

Contacts

Public ContactQiao Kong

Xuanwu Hospital, Capital Medical University

kongqiao@126.com+86 178 1205 0968

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 21, 2026